RK

Ravindra Kumar Deshwal

Active Director Additional Director DIN 10810899
DIN 10810899 First appointment Oct 2024
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Oct 2024
Shareholding value β€’β€’β€’β€’ Premium profile

About Ravindra Kumar Deshwal

Data last updated:

Ravindra Kumar Deshwal is an Additional Director at Vatkind Pharma Private Limited (since 2024).

DIN 10810899
Primary Designation Additional Director
First Appointment 18 Oct 2024
Oldest Company Age 2 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Vatkind Pharma Private Limited U47721RJ2024PTC097675
Additional Director18 Oct 20242024Active

Board colleagues of Ravindra Kumar Deshwal

NameDINCompanyDesignation
Laxmi Devi11371390Vatkind Pharma Private LimitedDirector
Manish Sharma10806709Vatkind Pharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Vatkind Pharma Private Limited
Premium access

Shareholding and investment profile for Ravindra Kumar Deshwal

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ravindra Kumar Deshwal

Ravindra Kumar Deshwal currently holds 1 directorship: Vatkind Pharma Private Limited (Additional Director, since 18 Oct 2024).

Ravindra Kumar Deshwal was first appointed on 18 Oct 2024 as Additional Director at Vatkind Pharma Private Limited.

The current boards of Ravindra Kumar Deshwal's companies include Laxmi Devi (Vatkind Pharma Private Limited), Manish Sharma (Vatkind Pharma Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available